The World Veterinary Vaccine Congress will focus on scientific an technological innovation in livestock vaccines, emerging diseases, influenza, companion vaccines and bioprocess and manufacture.
The 3rd Annual World Veterinary Vaccine Congress is the place where the global vaccine industry meets to discuss commercial and scientific issues around regulation, strategy, manufacturing, trials, and emerging diseases.
With the animal vaccines market predicted to be worth $8.6 billion by 2018, can you really afford not to be a core service provider for these manufacturers?
This event will provide a platform for you to showcase how you are moving veterinary vaccine development methods forward, from technology to regulation and manufacture.
SEE 2016 CONFERENCE AGENDA
BIOPROCESSING, DELIVERY AND MANUFACTURING
Optimize early formulation through to clinical manufacturing, by embracing new techniques and technologies
EMERGING AND RE-EMERGING DISEASES
Understand the opportunities for your business in reacting to global threats like malaria, dengue and Ebola
PRE-CLINICAL VALIDATION TO CLINICAL TRIALS
Assess how to improve your clinical trial performance, from developing novel immmunological assays to creating clinical efficacy
From livestock to companion, gain crucial insights into the emerging infections and new technologies changing the landscape
From new adjuvant technologies to novel immunotherapies, better understand the latest developments in the fast-evolving landscape whether you are interested in cancer and immunotherapy, allergy or chronic infectious diseases.
Discuss how profiling of the immune system using high throughput technologies can aid therapeutic design and treatment strategies in infectious and non-infectious diseases including cancer.
INFLUENZA AND RESPIRATORY
Find ways to improve development of universal influenza, RSV, MERS and Pneumococcal vaccines
Privacy statement »
Remember my details
Manage your email preferences »
You will be emailed the document as an attachment (707Kb in size)